Immunomodulator co-therapy is not superior to anti-TNF monotherapy at preventing first loss of response in inflammatory bowel disease patients: long term outcomes in a real world cohort

P. Varma, A. S. Rajadurai,D. Q. Holt,D. A. Devonshire,C. P. Desmond,M. P. Swan, D. Nathan, E. T. Shelton, I. Prideaux, C. Sorrell,F. Rusli, L. R. F. Crantock,A. T. Dev,D. T. Ratnam,S. Pianko,G. T. Moore

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY（2016）

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要